Blog Layout

Regenerative Medicines are Investing Billions in Results

Horse and companion owners are starting to see more and more information regarding regenerative and orthobiologic therapies for their animals. Regenerative and orthobiologic therapies are a form of therapy that allows the body to heal itself in a safe and non-toxic manner and holds much promise in managing pain and injuries. These therapies elicit a variety of biologic responses, such as stimulating growth factors, anti-inflammatory mediators and even the regeneration of tissue (Angelone, 2017).


In 2018, North America held the largest regenerative market share revenue and is projected to dominate the market. According to a recent study, the regenerative therapy market is expected to grow from 13.6 billion USD to 72.6 billion USD by 2026, expanding at a compound annual growth rate of 24.2%. This is due in part to their forecasted positive impact in healthcare to treat health conditions associated with cancer, neurology, orthopedics and potentially even certain genetic diseases. The funding of the global regenerative medicine market is what provides research and therapy dollars to drive the success of new regenerative therapies, like Alpha2EQ, making them safe and reliable (By, 2020).


Regenerative therapies allow the body to heal itself in a natural, safe and effective manner. Various regenerative therapies have been found to be extremely successful in providing instant pain-relief and targeted biologic treatment to ligament and tendon injuries. Because of its wide variety of relevance and substantial developments in tissue engineering, stem cell therapy, gene therapy and more, regenerative therapies will only continue to garner more awareness and support (Evans, 2019).


As more research is conducted, doctors and scientists are discovering more options in these therapies to treat pain, inflammation and musculoskeletal injuries suffered by equine, particularly those in high performance careers. Many universities and research organizations, such as Boise State University, will assist in propelling this growth by conducting studies that test different regenerative therapy approaches and techniques to ensure these treatments are safe and reliable when they get to market (Marycz, 2018).


This is an exciting advancement in the realm of animal medicine and, with the increases in funding, hold promise for effective and enduring treatment of animals that is both safe, comfortable and provides no proven adverse effects.


Read more about the studies that Astaria Global has conducted thus far here:

Equine Safety Study

Alpha-2 Macroglobulin: A Physiological Guardian


Angelone M, conti V, Biacca c, et al. the contribution of adipose tissue-derived mesenchymal stem cells and platelet-rich plasma to the treatment of chronic equine laminitis: a proof of concept. international Journal of Molecular Science. 2017;18(10). pii: e2122By. (2020, January 24). Regenerative Medicines Market Size, Status and Future Outlook 2020 to 2026. Retrieved February 12, 2020, from https://www.marketwatch.com/press-release/regenerative-medicines-market-size-status-and-future-outlook-2020-to-2026-2020-01-24

Evans, M. (2019, August 22). Regenerative Medicine. Retrieved February 12, 2020, from https://www.horsejournals.com/horse-care/alternative-therapies/regenerative-medicine

Marycz k, Michalak i, kornicka k. advanced nutritional and stem cells approaches to prevent equine metabolic syndrome. research in Veterinary Science. 2018;118:115-125.

Share by: